Glycogen Synthase Kinase-3 Alpha

E3195Hu

Sandwich

48T,96T

0.046ng/ml

0.1-35ng/ml

Serum, plasma, cell culture supernates

Human

2-8ºC

1h 30m

Constitutively active protein kinase that acts as a negative regulator in the hormonal control of glucose homeostasis, Wnt signaling and regulation of transcription factors and microtubules, by phosphorylating and inactivating glycogen Synthase (GYS1 or GYS2), CTNNB1/beta-catenin, APC and AXIN1 (PubMed: 11749387, PubMed: 17478001, PubMed: 19366350). Requires primed phosphorylation of the majority of its substrates (PubMed: 11749387, PubMed: 17478001, PubMed: 19366350). Contributes to insulin regulation of glycogen synthesis by phosphorylating and inhibiting GYS1 activity and hence glycogen synthesis (PubMed: 11749387, PubMed: 17478001, PubMed: 19366350). Regulates glycogen metabolism in liver, but not in muscle (By similarity). May also mediate the development of insulin resistance by regulating activation of transcription factors (PubMed: 10868943, PubMed: 17478001). In Wnt signaling, regulates the level and transcriptional activity of nuclear CTNNB1/beta-catenin (PubMed: 17229088). Facilitates amyloid precursor protein (APP) processing and the generation of APP-derived amyloid plaques found in Alzheimer disease (PubMed: 12761548). May be involved in the regulation of replication in pancreatic beta-cells (By similarity). Is necessary for the establishment of neuronal polarity and axon outgrowth (By similarity). Through phosphorylation of the anti-apoptotic protein MCL1, may control cell apoptosis in response to growth factors deprivation (By similarity). Acts as a regulator of autophagy by mediating phosphorylation of KAT5/TIP60 under starvation conditions, leading to activate KAT5/TIP60 acetyltransferase activity and promote acetylation of key autophagy regulators, such as ULK1 and RUBCNL/Pacer (PubMed: 30704899). Negatively regulates extrinsic apoptotic signaling pathway via death domain receptors. Promotes the formation of an anti-apoptotic complex, made of DDX3X, BRIC2 and GSK3B, at death receptors, including TNFRSF10B. The anti-apoptotic function is most effective with weak apoptotic signals and can be overcome by stronger stimulation (By similarity).

50,981

2931

Glycogen Synthase kinase-3 alpha;GSK 3A;GSK-3 alpha;GSK3A;Serine/threonine-protein kinase GSK3A

GSK3A

Cell Biology

GSK3A